OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Advances in Natural Product-Based Hybrids as Anti-Cancer Agents
Eleni Sflakidou, George Leonidis, Eirini Foroglou, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6632-6632
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Discovery of plant-derived anti-tumor natural products: Potential leads for anti-tumor drug discovery
Zi Hui, Hao Wen, Junlong Zhu, et al.
Bioorganic Chemistry (2023) Vol. 142, pp. 106957-106957
Closed Access | Times Cited: 37

Nature’s magic: how natural products work hand in hand with mitochondria to treat stroke
Lin Cheng, Shangbin Lv, Wei Chen, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 1

Natural product/diet-based regulation of macrophage polarization: Implications in treatment of inflammatory-related diseases and cancer
Milad Ashrafizadeh, Amir Reza Aref, Gautam Sethi, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 130, pp. 109647-109647
Closed Access | Times Cited: 6

Targeting programmed cell death in inflammatory bowel disease through natural products: New insights from molecular mechanisms to targeted therapies
Mengjie Wang, Zhiyuan Wang, Zhichao Li, et al.
Phytotherapy Research (2024)
Closed Access | Times Cited: 4

Aptamers for the Delivery of Plant-Based Compounds: A Review
Joana Gamboa, Pedro Lourenço, Carla Cruz, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 541-541
Open Access | Times Cited: 3

Discovery of a Hybrid Molecule with Phytotoxic Activity by Genome Mining, Heterologous Expression, and OSMAC Strategy
Yubo Lu, Yanpeng Li, Min Dou, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 33, pp. 18520-18527
Closed Access | Times Cited: 3

Pterostilbene suppresses gastric cancer proliferation and metastasis by inhibiting oncogenic JAK2/STAT3 signaling: In vitro and in vivo therapeutic intervention
Pengzhan He, Yangbo Li, Jiaming Hu, et al.
Phytomedicine (2023) Vol. 128, pp. 155316-155316
Closed Access | Times Cited: 7

Hybrid Heterocycles: Ag(I)-Catalyzed C–C/C–N/C–O Coupled Cascade Dual Cyclization to Valuable Indolo-4H-indolones and Indolo-4H-chromenes
Rajesh Nandi, Sk Ajarul, Prakash K. Mandal, et al.
The Journal of Organic Chemistry (2024) Vol. 89, Iss. 4, pp. 2556-2570
Closed Access | Times Cited: 2

Sophoraflavanone G: A review of the phytochemistry and pharmacology
Yingying Gao, Jialin Sun, Weinan Li, et al.
Fitoterapia (2024) Vol. 177, pp. 106080-106080
Closed Access | Times Cited: 2

Natural products‐based antiangiogenic agents: New frontiers in cancer therapy
Tiago Azevedo, Tiago Ferreira, Sheila I. Peña‐Corona, et al.
Food Frontiers (2024)
Open Access | Times Cited: 2

Synthesis of Oleanolic Acid-Dithiocarbamate Conjugates and Evaluation of Their Broad-Spectrum Antitumor Activities
Liyao Tang, Yan Zhang, Jinrun Xu, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1414-1414
Open Access | Times Cited: 4

Improving Properties of Podophyllic Aldehyde-Derived Cyclolignans: Design, Synthesis and Evaluation of Novel Lignohydroquinones, Dual-Selective Hybrids against Colorectal Cancer Cells
Ángela‐Patricia Hernández, Paula Díez, Pablo A. García, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 886-886
Open Access | Times Cited: 4

Synthesis and anticancer properties of a hybrid molecule with the testosterone and estradiol head-groups
Alexis Paquin, Fayanne Nolin, Chahrazed Bouzriba, et al.
Steroids (2024) Vol. 209, pp. 109469-109469
Closed Access | Times Cited: 1

Cucurbitacin B and Its Derivatives: A Review of Progress in Biological Activities
Wen-Zhe Nie, Yalan Wang, Xinlu Tian, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 4193-4193
Open Access | Times Cited: 1

Multi-target and natural product-based multi-drug approach for anti-VEGF resistance in glioblastoma
Sasikumar J. Soumya, Kesavan R. Arya, Chandran S. Abhinand, et al.
(2024), pp. 567-582
Open Access | Times Cited: 1

A Novel Life for Antitumor Combretastatins: Recent Developments of Hybrids, Prodrugs, Combination Therapies, and Antibody-Drug Conjugates
Marialuigia Fantacuzzi, Simone Carradori, Letizia Giampietro, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117021-117021
Open Access | Times Cited: 1

Rational Design, Synthesis and Binding Affinity Studies of Anthraquinone Derivatives Conjugated to Gonadotropin-Releasing Hormone (GnRH) Analogues towards Selective Immunosuppression of Hormone-Dependent Cancer
Georgia Biniari, Christos Markatos, Agathi Nteli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15232-15232
Open Access | Times Cited: 3

A Relay Ring-Closing Metathesis/Diels-Alder Approach to Sugar-Derived Pluramycin-Hybrids
A. K. Singh, Krishna P. Kaliappan
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 33, pp. 6727-6741
Closed Access

A New Frontier in Phytotherapy: Harnessing the Therapeutic Power of Medicinal Herb-derived miRNAs
Ya‐Long Feng
Current Pharmaceutical Design (2024) Vol. 30, Iss. 38, pp. 3009-3017
Closed Access

Page 1 - Next Page

Scroll to top